Therapeutic Goods Administration Considering New “Black Triangle” Warnings to Make Medicine Safer

☞ | View the text of this post. Exclusively available to ASQ Members.

New “black triangle” warnings are being considered by health authorities to alert patients and doctors about possible, unexpected side effects of new drugs.
The Therapeutic Goods Administration has released a consultation paper, flagging changes to make drugs and vaccines safer.
Under the proposals, black triangles would be used on new medicines or vaccines with provisional registration, suspected safety concerns or limited comparable international use.
“Rare adverse events may not be detected in clinical

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *